Company: LRHC
Filing Date: 2025-06-27
Form Type: S-1/A
Source: 0001213900-25-058528
Chunk: 11

Company: La Rosa Holdings Corp.
Filing Date: 2025-06-27
Form: S-1/A
Chunk 11
---
, as determined under the Securities Purchase Agreement. Such approval was effective on March 27,
2025, or 20 days after commencement of mailing of the definitive information statement regarding this approval to the stockholders of
the Company.

<div align='center'>2</div>

On June 18, 2025, with the prior approval
by the Company’s Board of Directors, the Company and the 2025 Investor entered into, and closed the transactions contemplated by,
that certain Amendment and Exchange Agreement (the “Exchange Agreement”) pursuant to which (among other things) the 2025
Investor surrendered and exchanged all of its Incremental Warrants in exchange for (the “Exchange”) 6,000 shares of the Company’s
Series B Convertible Preferred Stock, par value $0.0001 per share (“Series B Preferred Stock”). On the same date, the Company
filed a Certificate of Designation of Rights and Preferences of the Series B Preferred Stock (the “Certificate of Designation”)
with the Secretary of State of the State of Nevada. The Initial Note remains outstanding post-Exchange.

On June 26, 2025, the Company and 2025 Investor
signed an Amendment No. 1 to the Initial Note to correct an administrative error in the definition of maturity date and alternate conversion
price in the Initial Note.

Pursuant to the terms of the Exchange Agreement,
conversion of the Series B Preferred Stock into shares of common stock of the Company in excess of 19.99% of the Company’s outstanding
shares of common stock is conditional upon obtaining the approval of the Company’s stockholders in accordance with the rules and
regulations of the Nasdaq Capital Market. The Company agreed to convene a meeting of stockholders to obtain such approval within 120
days after the date of the Exchange Agreement.

Third Amended Agent Plan

On February 4, 2025, the Compensation Committee,
our Board of Directors, and the majority stockholders approved the Third Amended and Restated La Rosa Holdings 2022 Agent Incentive Plan
(“Third Amended Agent Plan”), which became effective on March 28, 2025.

The Third Amended Agent Plan revised the vesting
terms of the grants under Agent Equity Program and added new terms allowing the participants to authorize the Company to set aside 5%
of their agent net commissions on transactions in their name to purchase shares of the common stock at a 20% discount from the prior
30 day volume weighted average